Filters close
3-May-2022 1:05 PM EDT
CHOP Study Finds Neighborhood Poverty and Crowding Associated with Higher Rates of COVID-19 in Pregnancy
Children's Hospital of Philadelphia

Neighborhood characteristics, including poverty and crowding within homes, were associated with higher rates of SARS-CoV-2 in pregnancy during the prevaccination era of the pandemic, according to a new study led by researchers at Children’s Hospital of Philadelphia (CHOP). The findings, which were published today in the journal Obstetrics and Gynecology, may partially explain the high rates of COVID-19, the disease caused by SARS-CoV-2, among Black and Hispanic patients.

Released: 4-May-2022 10:05 AM EDT
Benefits of Exercise May Vary Greatly in Primary Mitochondrial Disease
Children's Hospital of Philadelphia

In a new study, researchers demonstrated that the benefits of endurance exercise can vary based on the type of mutation involved in mitochondrial disease, and while the benefits of exercise outweigh the risks, the mitochondrial genetic status of patients should be taken into consideration when recommending exercise as therapy.

21-Apr-2022 9:45 AM EDT
Study Suggests Policy, Education and Training Make Youngest Novice Drivers Better Prepared for License Exam, Less Likely to Crash
Children's Hospital of Philadelphia

Researchers found that new drivers licensed before age 18 who are subject to mandatory driver education, including behind-the-wheel training and Graduated Driver Licensing (GDL) restrictions, were less likely to crash than drivers licensed at age 18 who are exempt from these requirements.

13-Apr-2022 8:05 AM EDT
Structural Racism and Pandemic Stressors Associated with Postpartum Depression and Anxiety Among Black Individuals
Children's Hospital of Philadelphia

The combined effects of systemic and interpersonal racism layered on top of negative experiences within the COVID-19 pandemic were associated with depression and anxiety among Black people in the postpartum period, according to a new study by researchers in The Intergenerational Exposome Program (IGNITE) of Children’s Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of Pennsylvania. The findings were published today in JAMA Psychiatry.

Newswise: Treatment Developed by CHOP Researchers Prevents Hypoglycemia in Children with Hyperinsulinism
12-Apr-2022 10:05 AM EDT
Treatment Developed by CHOP Researchers Prevents Hypoglycemia in Children with Hyperinsulinism
Children's Hospital of Philadelphia

Researchers at Children’s Hospital of Philadelphia (CHOP) have shown that a targeted treatment they developed is effective at controlling blood sugar in patients with hyperinsulinism (HI), a genetic disease in which the pancreas produces too much insulin. The findings, which were published today in Diabetes Care, provide further evidence that the treatment could prevent hypoglycemia in patients with HI and may preclude the need for a full removal of their pancreas, a current standard treatment for severe diffuse HI.

4-Apr-2022 3:25 PM EDT
CHOP Researchers Create Reference Model for Brain Growth over Human Lifespan
Children's Hospital of Philadelphia

An international team including researchers from the Lifespan Brain Institute (LiBI) of Children’s Hospital of Philadelphia (CHOP) and the University of Pennsylvania have created a new tool that benchmarks brain development over the human lifespan, based on magnetic resonance imaging (MRI) data from more than 100,000 individuals. The work was jointly led by LiBI researchers and colleagues at the University of Cambridge. Described today in Nature, the interactive open resource, known as BrainChart, harmonizes brain images in a way that will allow researchers to measure brain development against reference charts like those used for evaluating children’s height and weight.

31-Mar-2022 9:55 AM EDT
Opioid Prescriptions for Pediatric Patients Following Surgical Procedures Have Dropped Significantly
Children's Hospital of Philadelphia

Researchers found that opioid prescriptions for children who underwent one of eight common outpatient surgeries declined over a period of five years. These findings suggest that clinicians are using more discretion when considering which pediatric patients require an opioid prescription after their procedures.

24-Mar-2022 4:05 PM EDT
CHOP Researchers Redefine the Mechanisms of Dravet Syndrome
Children's Hospital of Philadelphia

Researchers have found that dysfunction in an important cell subtype in the brain’s neuronal network contribute to chronic symptoms in the neurodevelopmental disorder Dravet syndrome.

Released: 10-Mar-2022 4:00 PM EST
CHOP-Led Study Finds Bortezomib Improves Survival in Children with Newly Diagnosed T-Cell Lymphoblastic Lymphoma
Children's Hospital of Philadelphia

Adding the proteasome inhibitor bortezomib to chemotherapy significantly improved overall survival in children and young adults with newly diagnosed T-cell lymphoblastic lymphoma (T-LL), according to a Children’s Oncology Group (COG) study led by researchers at Children’s Hospital of Philadelphia (CHOP). This international phase 3 clinical trial also found that radiation could be eliminated in 90% of children with T-cell acute lymphoblastic leukemia (T-ALL) when the chemotherapy regimen was intensified.

Released: 1-Mar-2022 2:20 PM EST
CHOP Researchers Show Early Developmental Delays Predict Poor Long-term Outcomes in Leigh Syndrome Patients
Children's Hospital of Philadelphia

Researchers have found that developmental delays associated with Leigh syndrome, the most common pediatric mitochondrial disorder, may occur earlier than previously recognized – even before metabolic stroke and regression – which could provide clinicians with an opportunity for earlier diagnosis and therapeutic interventions.

Released: 31-Jan-2022 9:45 AM EST
CHOP Researchers Define a 3-Tiered Molecular Classification of Pediatric Differentiated Thyroid Cancer, where Fusion Oncogenes Predict the Most Invasive Behavior
Children's Hospital of Philadelphia

Fusion oncogenes, such as RET- and NTRK-gene fusions, are associated with more invasive pediatric thyroid cancers, correlating with the highest risk of metastases and a lower likelihood of achieving remission one year after initial therapy, according to a new study by researchers at Children’s Hospital of Philadelphia (CHOP). The findings, which were published in the Journal of Clinical Oncology, contrast those previously established in adults, for whom BRAF mutations, not fusion oncogenes, are associated with more invasive disease that is less response to therapy.

Released: 27-Jan-2022 11:35 AM EST
CHOP Researchers Develop New Method for Measuring Movement Behavior in Children with Autism
Children's Hospital of Philadelphia

Researchers have developed a new method of measuring motor imitation, adding to a growing set of computational behavior analysis tools that can detect and characterize motor differences in children with autism.

Released: 25-Jan-2022 9:50 AM EST
CHOP Researchers Develop New Clinical Diagnostic Test to Identify Genetic Sources of Mitochondrial Disease
Children's Hospital of Philadelphia

Researchers have developed a comprehensive sequencing test specifically for mitochondrial DNA (mtDNA). This new clinical diagnostic test provides important information as to whether and to what level variations in the mtDNA are present in different tissues from a patient with suspected mitochondrial disease, leading to more precise diagnosis and more personalized treatment options.

10-Jan-2022 2:20 PM EST
CHOP Study Finds Infants with Low-Risk Deliveries Should Not Need Antibiotics at Birth
Children's Hospital of Philadelphia

Infants born via uncomplicated cesarean delivery, without labor or membrane rupture before delivery and no concern for infection, should not need antibiotics at birth, according to a study by researchers at Children’s Hospital of Philadelphia (CHOP). The findings, which were published today in Pediatrics, could help clinicians tailor the use of early antibiotics in newborns. Only those deemed at risk for infection should receive antibiotics, thereby reducing unnecessary use.

Newswise: Study Shows Climate Change Will Lead to Increase in Kidney Stones
5-Jan-2022 11:05 AM EST
Study Shows Climate Change Will Lead to Increase in Kidney Stones
Children's Hospital of Philadelphia

Rising temperatures due to climate change will lead to an increase in cases of kidney stones over the next seven decades, even if measures are put in place to reduce greenhouse gas emissions, according to a new study by researchers at Children’s Hospital of Philadelphia (CHOP). Based on data from South Carolina, the study found the increase will be steeper if no action is taken, but an uptick will occur even with mitigation actions, costing the state healthcare system approximately $57 million in the latter scenario and $99 million if nothing is done. The findings were published today in Scientific Reports.

Released: 4-Jan-2022 10:05 AM EST
Aberrant Splicing of CD22 in Acute Lymphoblastic Leukemia Underlies Resistance to Immunotherapy
Children's Hospital of Philadelphia

Aberrant splicing of messenger RNAs encoding surface antigen CD22 leads to downregulation of this protein in pediatric B-lymphoblastic leukemia (B-ALL), rendering malignant cells resistant to the effects of CD22-directed immunotherapies, according to a recent study by researchers at Children’s Hospital of Philadelphia (CHOP). The findings could allow oncologists to screen new patients to see if their leukemic cells contain alternatively spliced CD22 mRNA variants, which could reveal which patients might not respond to anti-CD22 therapies and would need alternative treatment plans. The study was published in Blood Cancer Discovery, a journal of the American Association for Cancer Research.

16-Dec-2021 2:30 PM EST
Family Members of Children with Life-Threatening Conditions 50% to 70% More Likely than Peers to Suffer Mental, Physical Issues
Children's Hospital of Philadelphia

Being the parent or sibling of a child with a life-threatening condition can take a mental and physical toll on other members of the family. A new study is one of the first to empirically measure the extent of this burden on families, with parents and siblings 50% to 70% more likely than their peers to receive health care for mental and physical health issues, accompanied by medication for these issues, than families of children without a life-threatening condition.

Released: 16-Dec-2021 9:45 AM EST
Study Finds Few Pediatric Providers Discuss Transportation With Their Autistic Patients
Children's Hospital of Philadelphia

A new study found that only 8% of pediatric healthcare and behavioral service providers feel prepared to assess whether their autistic patients are ready to drive. These findings suggest a critical need to develop resources that prepare providers and others who work with autistic youth to effectively facilitate independence and mobility as their patients become adults.

18-Nov-2021 5:05 PM EST
Researchers Use Model of Hypothalamus to Implicate Genes Associated with Sleep, BMI, Puberty, and More
Children's Hospital of Philadelphia

A new study has implicated several genes involved in a variety of bodily functions associated with the hypothalamus, a notoriously difficult-to-study region of the brain. The findings could help clinicians identify potential causes of dysfunction for many important traits regulated by the hypothalamus, such as sleep, stress, and reproduction.

15-Nov-2021 6:30 AM EST
CHOP-led Study Shows Novel Gene Therapy for Hemophilia A Leads to Sustained Expression of Clotting Factor and Reduced Bleeding Events
Children's Hospital of Philadelphia

A novel gene therapy for hemophilia A led to sustained expression of the clotting factor those patients lack, resulting in a reduction – or in some cases complete elimination – of painful and potentially life-threatening bleeding events, according to a new study led by researchers at Children’s Hospital of Philadelphia (CHOP). The results of the phase 1/2 trial, which were published today in the New England Journal of Medicine, are the first to demonstrate stable coagulation factor VIII in hemophilia A patients following gene therapy.



close
0.13503